Cargando…

The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database

BACKGROUND: The prevalence of fatty liver disease is potentially increasing in adolescents and young adults (AYAs) due to the obesity and alcohol pandemics. The aim of this study was to assess the prevalence of alcohol-associated fatty liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alkhouri, Naim, Almomani, Ashraf, Le, Phuc, Payne, Julia Y., Asaad, Imad, Sakkal, Celine, Vos, Miriam, Noureddin, Mazen, Kumar, Prabhat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338651/ https://www.ncbi.nlm.nih.gov/pubmed/35907827 http://dx.doi.org/10.1186/s12876-022-02430-7

Ejemplares similares

Simple diagnostic algorithm identifying at-risk nonalcoholic fatty liver disease patients needing specialty referral within the United States
por: Alkhouri, Naim, et al.
Publicado: (2022)

Characterization of patients with both alcoholic and nonalcoholic fatty liver disease in a large United States cohort
por: Khoudari, George, et al.
Publicado: (2019)

Noninvasive Testing Using Magnetic Resonance Imaging Techniques as Outcomes in Nonalcoholic Steatohepatitis Clinical Trials: How Full Is the Glass?
por: Noureddin, Nabil, et al.
Publicado: (2020)

Prevalence of at-risk NASH and its association with metabolic syndrome in US adults with NAFLD, 2017–2018
por: Payne, Julia Y., et al.
Publicado: (2023)

Prevalence of hypothyroidism and effect of thyroid hormone replacement therapy in patients with non-alcoholic fatty liver disease: A population-based study
por: Almomani, Ashraf, et al.
Publicado: (2022)

Prevalence of non-alcoholic fatty liver disease in patients with nephrotic syndrome: A population-based study
por: Onwuzo, Somtochukwu Stephen, et al.
Publicado: (2023)

Looking Into the Crystal Ball: Predicting the Future Challenges of Fibrotic NASH Treatment
por: Alkhouri, Naim, et al.
Publicado: (2019)

Epidemiology and prevalence of lean nonalcoholic fatty liver disease and associated cirrhosis, hepatocellular carcinoma, and cardiovascular outcomes in the United States: a population‐based study and review of literature
por: Almomani, Ashraf, et al.
Publicado: (2022)

Management of nonalcoholic fatty liver disease: Lessons learned from type 2 diabetes
por: Alkhouri, Naim, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease and type 2 diabetes: where do Diabetologists stand?
por: Tomah, Shaheen, et al.
Publicado: (2020)

Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+ and 4 scores
por: Noureddin, Mazen, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease prevalence and severity in Asian Americans from the national health and nutrition examination surveys 2017–2018
por: Truong, Emily, et al.
Publicado: (2022)

Non-high-density lipoprotein cholesterol (non-HDL-C) levels in children with nonalcoholic fatty liver disease (NAFLD)
por: Alkhouri, Naim, et al.
Publicado: (2014)

Low Serum Potassium Levels Associated with Disease Severity in Children with Nonalcoholic Fatty Liver Disease
por: Tabbaa, Adam, et al.
Publicado: (2015)

Diabetes and Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease
por: Teng, Pai-Chi, et al.
Publicado: (2023)

The Relationship between Nonalcoholic Fatty Liver Disease and Retinopathy in NHANES III
por: Lin, Tzu-Yu, et al.
Publicado: (2016)

Diet Quality Association with Nonalcoholic Fatty Liver Disease by Cirrhosis Status: The Multiethnic Cohort
por: Park, Song-Yi, et al.
Publicado: (2020)

Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
por: Alnimer, Lynna, et al.
Publicado: (2023)

The Development of the Pediatric NAFLD Fibrosis Score (PNFS) to Predict the Presence of Advanced Fibrosis in Children with Nonalcoholic Fatty Liver Disease
por: Alkhouri, Naim, et al.
Publicado: (2014)

Drug discovery and treatment paradigms in nonalcoholic steatohepatitis
por: Noureddin, Mazen, et al.
Publicado: (2019)

Epidemiology and risk of colorectal cancer in patients with a history of Helicobacter pylori infection: a population-based study
por: Boustany, Antoine, et al.
Publicado: (2023)

Cirrhotic patients on proton pump inhibitors are at a twofold risk of spontaneous bacterial peritonitis independently of gastrointestinal bleeding: a population-based retrospective study
por: Boustany, Antoine, et al.
Publicado: (2023)

Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among U.S. adolescents and adults: an association modified by race/ethnicity, NHANES 2005–2014
por: Frediani, Jennifer K., et al.
Publicado: (2018)

Predicting NAFLD prevalence in the United States using National Health and Nutrition Examination Survey 2017–2018 transient elastography data and application of machine learning
por: Noureddin, Mazen, et al.
Publicado: (2022)

Association Between Pulmonary Function and Nonalcoholic Fatty Liver Disease in the NHANES III Study
por: Peng, Tao-Chun, et al.
Publicado: (2015)

Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease
por: Mato, José M, et al.
Publicado: (2019)

Designing Clinical Trials in Pediatric Nonalcoholic Steatohepatitis: Tips for Patient Selection and Appropriate Endpoints
por: Alkhouri, Naim, et al.
Publicado: (2019)

Association between Dietary Niacin Intake and Nonalcoholic Fatty Liver Disease: NHANES 2003–2018
por: Pan, Jie, et al.
Publicado: (2023)

Machine learning models for predicting non-alcoholic fatty liver disease in the general United States population: NHANES database
por: Atsawarungruangkit, Amporn, et al.
Publicado: (2021)

Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial
por: Harrison, Stephen A., et al.
Publicado: (2023)

Perspectives on youth‐onset nonalcoholic fatty liver disease
por: Castillo‐Leon, Eduardo, et al.
Publicado: (2020)

What Does the Future Hold for Patients With Nonalcoholic Steatohepatitis: Diagnostic Strategies and Treatment Options in 2021 and Beyond?
por: Alkhouri, Naim, et al.
Publicado: (2021)

Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient‐Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis
por: Younossi, Zobair M., et al.
Publicado: (2021)

Prevalence and risk factors of nonalcoholic fatty liver disease, high-risk nonalcoholic steatohepatitis, and fibrosis among lean United States adults: NHANES 2017-2020
por: Kalligeros, Markos, et al.
Publicado: (2023)

Comparison between non-alcoholic fatty liver disease screening guidelines in children and adolescents
por: Ezaizi, Yamen, et al.
Publicado: (2019)

Hyperphosphorylation of hepatic proteome characterizes nonalcoholic fatty liver disease in S-adenosylmethionine deficiency
por: Robinson, Aaron E., et al.
Publicado: (2023)

Alcohol Consumption in Diabetic Patients with Nonalcoholic Fatty Liver Disease
por: Patel, Preya J., et al.
Publicado: (2017)

The effect of moderate alcohol drinking in nonalcoholic fatty liver disease
por: Choi, Jong Hwa, et al.
Publicado: (2020)

Alcohol consumption in patients with nonalcoholic fatty liver disease: yes, or no?
por: Protopapas, Adonis A., et al.
Publicado: (2021)

The effect of moderate alcohol consumption on nonalcoholic fatty liver disease
por: Park, Ji-Won, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_90cokaogmpb3qtl3osgnanfaum